2005, Vol. 17, No. 3 , Pages 181-188 (doi:10.1080/09540260500093768)
PDF (82 KB)
PDF Plus (87 KB)
M. Bonati and A. Clavenna
Laboratory for Mother and Child Health, ‘Mario Negri’ Pharmacological Research Institute, Milan, Italy
Despite the scarcity of evidence on the safety and efficacy of psychotropic drugs in the paediatric population, especially in the long-term, several epidemiological studies have reported an increase in their prescription rates. This increase is especially evident for stimulants and selective serotonin reuptake inhibitors. An analysis of the epidemiological data suggests that the risk of inappropriate use or abuse of these drugs is high. In such a context, not only is additional, independent and transparent research necessary, but also children with mental disorders (and their parents) must be guaranteed appropriate care.
Read More: http://informahealthcare.com/doi/abs/10.1080/09540260500093768
Psychotropic prescribing practices of paediatricians in the UK
Article first published online: 7 JUL 2008
Child: Care, Health and Development
Volume 27, Issue 6, pages 497–508, November 2001
This study examines the prescribing practices and attitudes to psychotropic medication by paediatricians in the UK.
Questionnaires were sent to 100 randomly chosen paediatricians in the UK to assess their prescribing practices of psychotropic medication in children.
Paediatricians see and treat many children with a wide variety of psychotropic medications on a regular basis. However, few of them feel competent, and most requested regular psychopharmacology seminars.
In the US, primary care physicians and paediatricians are recognized as primarily responsible for the continuing increase in psychotropic prescriptions in children. This study shows that, in the UK, paediatricians also contribute to such prescribing and need to be taken into account when estimating the prevalence and appropriateness of such medication use in children.
AND THE SITUATION HAS DETERIORATED EXPONENTIALLY SINCE THEN.